---
title: Schedule
layout: page
---

The 2018 meeting will be held November 7–10 at the Marine Biological Laboratory in Woods Hole, MA. All talks will take place at the Lillie auditorium. The poster session, meals, and mixers will be held in the Swope center.

### Wednesday, November 7

Check-in at MBL (2:00 – 9:00 pm)

Dinner (5:30 – 7:00 pm)

Opening Keynote (7:00 – 8:00 pm)  
*Christina Leslie (Memorial Sloan Kettering Cancer Center)*

Networking Mixer (8:30 – 10:30 pm)

### Thursday, November 8

Breakfast (7:30 – 8:30 am)

**Session #1: Tumor Heterogeneity** (9:00 – 10:40 am)  

- *Invited Speaker:* Shannon Mumenthaler (University of Southern California)
- Paul Macklin (Indiana University): *Open source software for studying 3-D multicellular cancer systems biology in high throughput*
- Christopher McFarland (Stanford University): *Traversing the fitness landscape of lung adenocarcinoma in vivo using tumor barcoding and CRISPR/Cas9-mediated genome editing*
- B. Bishal Paudel (Vanderbilt University): *Drug Response Epigenetic Landscape of BRAF-mutated Melanoma Cells*
- Susanne Tilk (Stanford University): *Effects of genome-wide mutation rates on the accumulation of deleterious mutations in cancer*

**Poster Session #1** (10:50 am – 12:00 pm)  
Coffee served.

Lunch with "Meet the PIs" mentoring opportunity (12:15 – 1:30 pm)

 **Session #2: Microenvironment and Metastasis** (1:45 – 3:25 pm)  

- *Invited speaker:* Andrew Ewald (Johns Hopkins University)
- Hunter Boyce (Stanford University): *Spatial analysis of multiplex immunohistochemistry data enables systems analysis of hypoxia and improved stratification of lung cancer patient outcomes*
- Aedin Culhane (DFCI): *Extracting the latent signals of tumor seed/soil using matrix factorization approaches*
- Andrew Gentles (Stanford University): *Pan-cancer analysis of time-to-distant metastasis in the context of node-positive and node-negative disease*
- Daniel Ortiz (UCSD): *ECM-driven stress leads to cancer cell transdifferentiation and collective migration*

Coffee Break (3:25 – 3:45 pm)

**Session #3: Translational Systems Biology** (3:45 – 5:25 pm)  

- *Invited speaker:* Robert Gatenby (Moffitt Cancer Center)
- Robert Gatenby (Moffitt Cancer Center): *Evolutionary dynamics in cancer therapy*
- Amy Brock (UT Austin): *Lineage-resolved analysis of chemoresistance strategies and clonal dynamics*
- Sagar Chhangawala (MSKCC): *Chromatin accessibility maps of Recurrence in Pancreatic Cancer*
- Luciane Kagohara (John Hopkins University): *Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance*
- Jason Sheltzer (Cold Spring Harbor Labs): *Genetic determinants of cancer patient outcome*

Dinner (5:45 – 7:15 pm)

Meet the Editors Panel Discussion (7:15 – 8:15 pm)

Networking Mixer (8:30 – 10:30 pm)

### Friday, November 9

AECCSB Business Meeting (7:15 – 8:15 am)

Breakfast (7:30 – 8:30 am)

**Session #4: Systems Immunology & Immunotherapy** (9:00 – 10:40 am)  

- *Invited speaker:* Ilya Shmulevich (Institute for Systems Biology): *The Immune Landscape of Cancer*
- Philipp Altrock (Moffitt): *Evolutionary dynamics of non-Hodgkin's lymphoma CAR T cell therapy*
- Jennifer Oyler-Yaniv (UCLA): *Catch and Release of Cytokines Mediated by Tumor Phosphatidylserine Converts Transient Exposure into Long-Lived Inflammation*
- Nathan Reticker-Flynn (Stanford): *Lymph node colonization promotes distant tumor metastasis through the induction of systemic immune tolerance*
- Siranush Sarkizova (Harvard/Broad): *More accurate prediction of epitope presentation in tumors for cancer vaccines based on large datasets of HLA-associated epitopes*

**Poster Session #2** (10:50 am – 12:00 pm)  
Coffee served.

Lunch + "Meet the PIs" Lunch Tables (12:15 – 1:30 pm)

**Session #5: Systems Pharmacology** (1:45 – 3:25 pm)  

- *Invited speaker:* Saroja Ramanujan (Genentech)
- Arvind Singh Mer (University of Toronto): *Systematic assessment of genomic biomarkers for drug sensitivity prediction in patient derived xenografts*
- Beril Tutuncuoglu (UCSF): *CRISPR-Cas9 based platform reveals PARP-inhibitor hypersensitivity of cells deficient in novel BRCA1-interactors*
- David Wooten (Vanderbilt): *Quantifying drug combination synergy along axes of potency and efficacy*
- Molly Carroll (University of Wisconsin-Madison): *Moving beyond genetic mutations to predict response to targeted therapies*

Coffee Break (3:25 – 3:45 pm)

***Systems Biology Bench to Bedside #1*** (3:45 – 5:25 pm)  
Invited speakers:  
*Garry Nolan (Stanford University)*  
*Louis Weiner (Georgetown University)*

Dinner (5:45 – 7:15 pm)

***Systems Biology Bench to Bedside #2*** (7:15 – 8:45 pm)  
Invited speakers:  
*Rosalie Sears (Oregon Health & Science University)*  
*Victoria Seewaldt (City of Hope)*

### Saturday, November 10

Breakfast (7:30 – 8:30 am)

**Session #6: Signaling Networks in Cancer** (9:00 – 10:40 am)  

- *Invited speaker:* Ursula Klingmüller (DKFZ)
- Eric Batchelor (NCI): *Defining the network architecture coordinating double strand break repair and p53 dynamics*
- Sean Gross (OHSU): *Accurate transmission of IGF-I into AKT signaling activity in individual cells*
- James Joly (USC): *PKA-mediated glycogen catabolism promotes cancer cell resistance to glucose deprivation*
- Manu Kumar (MIT): *Computational analysis of single-cell RNA-sequencing identifies tumor microenvironment cell-cell communication*

Coffee Break (10:40 am – 11:00 am)

Closing Keynote (11:00 am – 12:00 pm)  
*Joe Gray (Oregon Health & Science University)*

Note: *Invited talks will be limited to 30 minutes with 10 minutes for questions. Selected talks will be limited to 12 minutes with 3 minutes for questions.*
